Display Settings:

Format

Send to:

Choose Destination
    J Clin Psychiatry. 1990 May;51(5):200-2.

    A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.

    Source

    Department of Psychiatry, University of Wisconsin Hospital, Madison 53792.

    Abstract

    The authors employed a double-blind, placebo-controlled design to investigate the effectiveness of fluvoxamine versus imipramine in 54 outpatients with moderate major depression. Fluvoxamine proved superior to placebo but not to imipramine on the Hamilton Rating Scale for Depression and the Montgomery and Asberg Depression Rating Scale. Nausea and hyperarousal were the most common side effects in the fluvoxamine-treated patients.

    PMID:
    2110560
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk